SMT201400121B - Composizione in combinazione, compredente come ingrediente attivo l-carnitina o propionil l-carnitina, per la prevenzione o il trattamento dell'insufficienza venosa cronica - Google Patents

Composizione in combinazione, compredente come ingrediente attivo l-carnitina o propionil l-carnitina, per la prevenzione o il trattamento dell'insufficienza venosa cronica

Info

Publication number
SMT201400121B
SMT201400121B SM201400121T SM201400121T SMT201400121B SM T201400121 B SMT201400121 B SM T201400121B SM 201400121 T SM201400121 T SM 201400121T SM 201400121 T SM201400121 T SM 201400121T SM T201400121 B SMT201400121 B SM T201400121B
Authority
SM
San Marino
Prior art keywords
carnitine
propionyl
prevention
treatment
active ingredient
Prior art date
Application number
SM201400121T
Other languages
English (en)
Inventor
Mohammed Ashraf Virmanin
Aleardo Koverech
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51844410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201400121(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP10152363A external-priority patent/EP2353596A1/en
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of SMT201400121B publication Critical patent/SMT201400121B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201400121T 2010-02-02 2014-09-01 Composizione in combinazione, compredente come ingrediente attivo l-carnitina o propionil l-carnitina, per la prevenzione o il trattamento dell'insufficienza venosa cronica SMT201400121B (it)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10152363A EP2353596A1 (en) 2010-02-02 2010-02-02 Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
US32253210P 2010-04-09 2010-04-09
EP11709464.9A EP2531189B1 (en) 2010-02-02 2011-02-07 Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
PCT/IB2011/000200 WO2011095882A1 (en) 2010-02-02 2011-02-07 Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency

Publications (1)

Publication Number Publication Date
SMT201400121B true SMT201400121B (it) 2014-11-10

Family

ID=51844410

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400121T SMT201400121B (it) 2010-02-02 2014-09-01 Composizione in combinazione, compredente come ingrediente attivo l-carnitina o propionil l-carnitina, per la prevenzione o il trattamento dell'insufficienza venosa cronica

Country Status (6)

Country Link
CA (1) CA2787470C (it)
CL (1) CL2012001740A1 (it)
HR (1) HRP20140785T1 (it)
MY (1) MY182607A (it)
SM (1) SMT201400121B (it)
ZA (1) ZA201206518B (it)

Also Published As

Publication number Publication date
ZA201206518B (en) 2013-05-29
CA2787470C (en) 2018-03-27
HRP20140785T1 (hr) 2014-11-07
MY182607A (en) 2021-01-26
CA2787470A1 (en) 2011-08-11
CL2012001740A1 (es) 2012-11-09

Similar Documents

Publication Publication Date Title
PL2531189T3 (pl) Kompozycja kombinacyjna zawierająca jako składniki czynne L-karnitynę lub propionylo-L-karnitynę do zapobiegania lub leczenia przewlekłej niewydolności żylnej
SMT201600055B (it) Composizione farmaceutica per il trattamento o la prevenzione del glaucoma
IT1402907B1 (it) Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.
BRPI0924425A2 (pt) "combinações de substâncias ativas sinergéticas".
IT1404931B1 (it) Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
BRPI1013245A2 (pt) "composto para o tratamento de distúrbios metabólicos"
SMT201500124B (it) Composizioni di bifosfonati e metodi per il trattamento dell'insufficienza cardiaco
SG10201501579WA (en) Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
IT1406864B1 (it) Composizione per il trattamento dell'acne
BR112013015048A2 (pt) composição para o tratamento de distúrbios metabólicos
IT1397446B1 (it) Compositions comprising amino acids for prevention and/or treatment of renal disorders.
BR112014004737A2 (pt) composto de composição de cloridrato de ambroxol e método de preparação do composto
SMT201600268B (it) Composizione per il trattamento delle neuropatie
BR112013007039A2 (pt) "composição de tratamento pessoal"
IT1402712B1 (it) Unita' per l'esecuzione di trattamenti estetici, cosmetici e terapeutici.
SMT201400121B (it) Composizione in combinazione, compredente come ingrediente attivo l-carnitina o propionil l-carnitina, per la prevenzione o il trattamento dell'insufficienza venosa cronica
IT1397023B1 (it) Composizioni comprendenti amminoacidi, per il trattamento della broncopneumopatia cronica ostruttiva
ITTO20080021A1 (it) Calzatura, in particolare per la prevenzione e la correzione dell'alluce valgo
IT1401083B1 (it) Composizione per il trattamento e la prevenzione dell'herpes simplex labiale.
PL2699545T3 (pl) Nowe pochodne aminopirolinowe, ich zastosowanie w zapobieganiu i/lub leczeniu zespołu metabolicznego
BRPI1008207A2 (pt) "composição farmacêutica para tratamento de efeitos colateriais por administração de spiegelmers."
IT1397219B1 (it) Composizione farmaceutica o dietetica per il trattamento dell'atopia
IT1396436B1 (it) Composizione per la prevenzione ed il trattamento delle patologie odontostomatologiche degli animali e relativi usi.
PT2686005T (pt) Composições tópicas compreendendo diamina oxidase para o tratamento ou prevenção de doenças associadas com elevados níveis de histamina que envolvem um aumento na dor
IT1391928B1 (it) Integratore alimentare per il trattamento di neuropatie